Abstract
Dialysis is an effective treatment for chronic renal failure or uremia. Unfortunately, 85% of the world’s uremic patients die because their countries cannot afford dialysis therapy. Even in those countries that are treating the other 15% of the uremic patients, the total healthcare cost for this has been escalating to high levels. This is partly because success in the expensive dialysis treatment can now maintain uremic patients alive. This results in continuing increases in the number of dialysis patients. In any case, most patients would prefer an oral form of therapy rather than being attached to dialysis machines or receiving peritoneal dialysis. Many groups have studied a more affordable form of oral therapy for many years. A combination of adsorbents, osmotic agents, and other oral agents can control most of the problems related to accumulation of waste metabolites and water and electrolyte imbalances. Unfortunately, these groups ended their attempts at this many years ago because of the unavailability of an effective urea removal system. The hypothesis that high levels of ammonia can lead to hepatic comas in liver failure i receiving increasing support. An effective and fast ammonia removal system would therefore be useful here also. This chapter discusses the use of artificial cells for urea and ammonia removal, with emphasis on the use of encapsulated E. coli DH5 cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bruni S, Chang TMS. 1989. Hepatocytes immobilized by microencapsulation in artificial cells: Effects on hyperbilirubinemia in Gunn rats. J. Biomat. Artif. Cells and Artif. Organs, 17: 403–412.
Bruni S, Chang TMS. 1991. Encapsulated hepatocytes for controlling hyperbilirubinemia in Gunn rats. Int. J. Artificial Organs, 14: 239–241.
Bruni S, Chang TMS. 1995b. Kientic analysis of UDPglycoronosyl-transferase in bilirubin conjugation by encapsulated hepatocytes for transplantation into rats. Artif. Org., 19: 449–457.
Bruni S, Chang TMS. 1995a. Effect of donor strains and age of the recipient in the use of microencapsulated hepatocytes to control hyperbilirubinemia in the Gunn rat. Int. J. Artif. Org., 18:332–339.
Cai ZH, Shi ZQ, Sherman M, Sun AM. 1989. Development and evaluation of a system of microencapsulation of primary rat hepatocytes. Hepatology, 10: 885–860.
Chang TMS. 1964. Semipermeable microcapsules. Science, 146: 524–525.
Chang TMS. 1966. Semipermeable aqueous microcapsules (“artificial cells”): with emphasis on experiments in an extracorporeal shunt system. Trans. Am. Soc. Artif. Intern. Organs, 12: 13–19.
Chang TMS, Macintosh FC, Mason SG. 1966. Semipermeable aqueous microcapsules: I. Preparation and properties. Can. J. Physiol. Pharmacol., 44: 115–128.
Chang TMS, Macintosh FC, Mason SG. 1971. Encapsulated hydrophilic compositions and methods of making them. Canadian Patent, 873, 815.
Chang TMS. 1972. Artificial cells. Monograph. Springfield, IL: Charles C. Thomas Publisher.
Chang TMS. 1976. Microcapsule artificial kidney: Including updated preparative procedures and properties. Kidney Int., 10: S218–S224.
Chang TMS, Malouf C. 1979. Effects of glucose dehydrogenase in converting urea and ammonia into amino acid using artificial cells. Artif. Organs, 31: 38–41.
Chang TMS, Wong H. 1992. A novel method for cell encapsulation in artificial cells. USA Patent No. 5,084,350.
Chang TMS. 1995. Artificial cells with emphasis on bioencapsulation in biotechnology. Biotechnology Annual Review, 1:267–295.
Chang TMS, Prakash S. 1996. Artificial cells microencapsulated cells and genetically engineered E. coli DH 5 cells for cell therapy, gene therapy, and the removal of urea and ammonia. In: Methods in molecular biology, Vol. 63 RS Tuan (editor) New York: Humana Press, 343–358.
Chang TMS. 1997. Artificial cells. In: Encyclopedia of human biology (2nd Edition), Dulbecco, Renalo (editor-in-chief) San Diego, CA: Academic Press, Inc., pp. 457–463.
Coromili V, Chang TMS. 1993. Poly dispersed dextran as a diffusing test solute to study the membrane permeability of alginate polylysine microcapsules. Biomaterials, Artificial Cells and Immobilization Biotechnology, 21: 323–335.
Dixit V, Gordon VP, Pappas SC, Fisher MM. 1989. Increased survival in galactosamine induced fulminant hepatic failure in rats following intraperitoneal transplantation of isolated encapsulated hepatocytes. In: Hybrid artificial organs, Vol 177, Baquey C, Dupuy B (editors) Paris, France: Colloque ISERM, 257–264.
Dixit V, Arthur M, Gitnick G. 1992. Repeated transplantation of microencapsulated hepatocytes for sustained correction of hyperbilirubinemia in Gunn rats. Cell Transplant. 1:275–279.
Gu KF, Chang TMS. 1988. Conversion of ammonia or urea into L-leucine, L-valine, and L-isoleucine using artificial cell immobilizing multienzyme system and dextran-NADH+. I. Glucose dehydrogenase for cofactor recycling. ASAIO, 11: 24–28.
Gu KF, Chang TMS. 1990. Production of essential L-branched-chained amino acids, in bioreactors containing artificial cells immobilized multienzyme systems and dextran-NAD. Applied Biochemistry and Biotechnology, 26: 263–269.
Kashani S, Chang TMS. 1991b. Physical chemical characteristics of hepatic stimulatory factor prepared from cell free supernatant of hepatocyte cultures. Biomaterials, Artificial Cells and Immobilization Biotechnology, 19: 565–578.
Kashani S, Chang TMS. 1991a. Effects of hepatic stimulatory factor released from free or microencapsulated hepatocytes on galactosamine induced fulminant hepatic failure animal model. Biomaterials, Artificial Cells and Immobilization Biotechnology, 19: 579–598.
Kjellstrand C, Borges H, Pru C, Gardner D, Fink D. 1981. On the clinical use of microencapsulated zirconium phosphate-urease for the treatment of chronic uremia. Trans. Am. Soc. Artif. Intern. Org., 27: 24–30.
Prakash S, Chang TMS. 1993. Microencapsulated genetically engineered E. coli cells containing genes from K. aero gens for urea and ammonia removal. Biomat. Artifi. Cells Immob. Biotechnol, 19: 687–697.
Prakash S, Chang TMS. 1995. Preparation and in-vitro analysis of genetically engineered E. coli cells, microencapsulated in artificial cells for urea and ammonia removal. Biotechnology and Bioengineering, 46:687–697.
Prakash S, Chang TMS. 1996. Microencapsulated genetically engineered live E. coli DH 5 cells given orally to maintain normal plasma urea level in uremic rats. Nature Medicine, 2(8): 893–887.
Scott B, Mulrooney H, Stuart P, Haussinger RP. 1989. Regulation of gene expression and cellular localization of cloned K. aero gens urease. J. Gen. Microbiol, 135: 1769–17
Setala K, Heinonen H, Schreck-Purla I. 1973. Ingestion of lyophilized soil bacteria for alleviation of uremic symptoms. J. Int. Res. Comm. Syst., 73: 1.
Sparks RE. 1979. Review of gastrointestinal perfusion in treatment of uremia. Clin. Nephrol, 11: 81.
Wong H, Chang TMS. 1986. Bioartificial liver: Implanted artificial cells microencapsulated living hepatocytes increases survival of liver failure rats. Int. J. Artif. Organs, 9: 335–6.
Wong H, Chang TMS. 1988. The viability and regeneration of artificial cell microencapsulated rat hepatocyte xenograft transplants in mice. Biomat. Artif. Cells and Artif. Organs, 16:731–740.
Wong H, Chang TMS. 1991b. Microencapsulation of cells within alginate poly-L-lysine microcapsules prepared with standard single step drop technique: Histologically identified membrane imperfections and the associated graft rejection. J. Biomaterials, Artificial Cells and Immobilization Biotechnology, 19: 675–686.
Wong H, Chang TMS. 1991a. A novel two step procedure for immobilizing living cells in microcapsules for improving xenograft survival. Biomaterials, Artificial Cells and Immobilizing Biotechnology, 19: 687–698.
Wrong OM, Edmonds CJ, Chadwick VS. 1981. The large intestine, Lancaster: MTP Press.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chang, T.M.S., Prakash, S. (1999). Removal of Urea in Uremia and Ammonia in Liver Failure with Emphasis on the Use of Artificial Cells for Encapsulation of Genetically Engineered Cells. In: Kühtreiber, W.M., Lanza, R.P., Chick, W.L. (eds) Cell Encapsulation Technology and Therapeutics. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4612-1586-8_29
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1586-8_29
Publisher Name: Birkhäuser, Boston, MA
Print ISBN: 978-1-4612-7205-2
Online ISBN: 978-1-4612-1586-8
eBook Packages: Springer Book Archive